XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
OPERATING ACTIVITIES:    
Net Income $ 116,264 $ 135,504
Items not affecting cash:    
Depreciation and depletion 145,705 140,896
Amortization of debt issuance costs, discount and deferred hedge gain 4,044 3,951
Stock-based compensation costs 4,324 5,850
Equity portion of allowance for funds used during construction (9,983) (7,829)
Loss on disposition of assets 524 6,536
Deferred income taxes (12,127) (681)
Changes in current assets and liabilities:    
Accounts receivable 49,522 28,901
Inventories (48,639) (23,400)
Other current assets (5,139) (8,442)
Accounts payable 36,064 (12,472)
Accrued expenses and other 67,636 85,015
Regulatory assets (20,788) (67,672)
Regulatory liabilities (6,398) (32,941)
Other noncurrent assets 8,968 610
Other noncurrent liabilities (20,707) (32,216)
Cash Provided by Operating Activities 309,270 221,610
INVESTING ACTIVITIES:    
Property, plant, and equipment additions (386,339) (311,160)
Investment in equity securities (914) (655)
Cash Used in Investing Activities (387,253) (311,815)
FINANCING ACTIVITIES:    
Proceeds from Issuance of Common Stock 179,903 121,066
Dividends on common stock (102,980) (95,148)
Issuance of long-term debt, net 0 99,915
Line of credit borrowings, net 12,000 73,000
Payment for Debt Extinguishment or Debt Prepayment Cost 0 (955)
Repayments of short-term borrowings 0 (100,000)
Proceeds from (Payments for) Other Financing Activities (977) (550)
Cash Provided by Financing Activities 87,946 97,328
Increase in Cash, Cash Equivalents, and Restricted Cash 9,963 7,123
Cash, Cash Equivalents, and Restricted Cash, beginning of period 18,762 17,096
Cash, Cash Equivalents, and Restricted Cash, end of period  28,725 24,219
Cash paid during the period for:    
Income taxes 9,060 3,630
Interest 60,610 57,473
Significant non-cash transactions:    
Capital expenditures included in accounts payable $ 26,184 $ 23,500